APA 6th Edition

Perić, P. (2013). Alfacalcidol (Alpha D3®) - a novel agent in treatment of patients with vitamin D deficiency and osteoporosis in Croatia. Reumatizam, 60 (2), 181-182. Retrieved from https://hrcak.srce.hr/123457

---

MLA 8th Edition

Perić, Porin. "Alfacalcidol (Alpha D3®) - a novel agent in treatment of patients with vitamin D deficiency and osteoporosis in Croatia." Reumatizam, vol. 60, no. 2, 2013, pp. 181-182. https://hrcak.srce.hr/123457. Accessed 18 May 2024.

---

Chicago 17th Edition

Perić, Porin. "Alfacalcidol (Alpha D3®) - a novel agent in treatment of patients with vitamin D deficiency and osteoporosis in Croatia." Reumatizam 60, no. 2 (2013): 181-182. https://hrcak.srce.hr/123457

---

Harvard

Perić, P. (2013). 'Alfacalcidol (Alpha D3®) - a novel agent in treatment of patients with vitamin D deficiency and osteoporosis in Croatia', Reumatizam, 60(2), pp. 181-182. Available at: https://hrcak.srce.hr/123457 (Accessed 18 May 2024)

---

Vancouver

Perić P. Alfacalcidol (Alpha D3®) - a novel agent in treatment of patients with vitamin D deficiency and osteoporosis in Croatia. Reumatizam [Internet]. 2013 [cited 2024 May 18];60(2):181-182. Available from: https://hrcak.srce.hr/123457

---

IEEE

P. Perić, "Alfacalcidol (Alpha D3®) - a novel agent in treatment of patients with vitamin D deficiency and osteoporosis in Croatia", Reumatizam, vol.60, no. 2, pp. 181-182, 2013. [Online]. Available: https://hrcak.srce.hr/123457. [Accessed: 18 May 2024]